文献速递产科母胎医学

NIPT低风险后颈项透明层增厚:应向准父母说明什么

Increased nuchal translucency after low-risk noninvasive prenatal testing: What should we tell prospective parents?
PubMed 文献 · Prenat Diagn · 2021-08-06

本文讨论在无创产前检测(NIPT)低风险背景下,早孕期超声发现孤立性颈项透明层(NT)增厚时的临床咨询与管理困境。文章回顾NT联合血清标志物与 maternal age 的一线联合筛查(FTCS)历史,指出NIPT改变了传统路径但11–13周NT超声对结构异常筛查仍重要。作者汇总父母与临床医生的常见问题并提出建议管理路径。

要点

  • NIPT低风险不能替代11–13周NT超声对结构异常的筛查价值。
  • 孤立性NT增厚且NIPT低风险时,需向父母说明后续分层检查与不确定预后。
  • 从早孕期诊断到22–24周逐步获得预后信息,对父母情绪挑战大,需持续沟通。

核心结论

  • NIPT低风险后发现的孤立性NT增厚构成新的临床咨询难题,需向准父母说明不确定性与后续检查路径。

研究设计与样本

  • 本文为针对NIPT低风险后NT增厚临床咨询与管理的综述性讨论,未报告原始研究样本量。

主要发现

  • 三十年前观察到早孕期颈后多余液体积聚的胎儿更可能为非整倍体,促成了产前筛查新时代。
  • NT测量联合血清生物标志物与 maternal age 形成了早孕期联合筛查(FTCS)方案。
  • 过去十年引入的NIPT可在最早10周妊娠起对常见三体提供高敏感性与特异性筛查信息,改变了传统FTCS路径。
  • 保留11–13周NT超声对结构异常检测仍重要。
  • 在先进基因组检测时代,NIPT低风险且孤立性NT增厚的最佳管理是临床医生的新困境。

临床怎么用

  • 对NIPT低风险但NT增厚的孕妇,应就后续分层检查与各阶段预后信息进行充分咨询。
  • 临床医生需关注从早孕期诊断到22–24周逐步获取预后信息期间父母的情感挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Three decades ago, the observation that first trimester fetuses with excess fluid accumulation at the back of the neck were more likely to be aneuploid, gave rise to a new era of prenatal screening. The nuchal translucency (NT) measurement in combination with serum biomarkers and maternal age, resulted in the first trimester combined screening (FTCS) program. The introduction of noninvasive prenatal testing (NIPT) over the past decade has introduced the option for parents to receive highly sensitive and specific screening information for common trisomy from as early as 10 weeks gestation, altering the traditional pathway FTCS pathway. The retention of the 11-13-week NT ultrasound remains important in the detection of structural anomalies; however, the optimal management of pregnancies with a low-risk NIPT result and an isolated increased NT measurement in an era of advanced genomic testing options is a new dilemma for clinicians. For parents, the prolonged period between the initial diagnosis in first trimester, and prognostic information at each successive stage of investigations up to 22-24 weeks, can be emotionally challenging. This article addresses the common questions from parents and clinicians as they navigate the uncertainty of having a fetus diagnosed with an increased NT after a low-risk NIPT result and presents suggested approaches to management.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Kelley J, McGillivray G, Meagher S, et al. Increased nuchal translucency after low-risk noninvasive prenatal testing: What should we tell prospective parents? Prenat Diagn. 2021. PMID: 34297420. doi:10.1002/pd.6024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。